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Introduction 
In childhood, prior to adolescence, vaginal bleed-
ing is only rarely a problem. During adolescence, 
however, vaginal bleeding (or the lack of it) is a 
common complaint. 
The average age of first vaginal bleeding, or men-
arche, in the United States is between 12.5 and 13 
years. Around two years prior to this, however, there 
has been budding of breasts and the appearance of 
pubic hair. During the year before menarche, there is 
pigmentation of the nipples and the breasts fill out. 
Axillary hair does not appear until about the same 
time as the first menses. 
The degree of skeletal maturation is a better indi-
cator of the stage of a girl's development than her 
chronologic age. It is generally agreed that most girls 
have their first menstrual period when their skeletal 
age is between 13.5 and 14 years, regardless of their 
chronologic age. 
The average menstrual cycle lasts 28 or 29 days, 
although cycles from 21 to 40 days are considered 
within physiologic limits. The normal human female 
usually ovulates between the 11th and 17th day of the 
menstrual cycle; this is usually 14 days before the 
beginning of the next menstrual flow. The bleeding 
usually lasts from 3 to 7 days and blood loss is about 
60 ml. Normal menstrual bleeding consists of a slough-
ing off of the more superficial portions of the endo-
metrium, leaving only the basal layer. This occurs 
when the endometrium has been caused to proliferate 
by priming with estrogen and then is converted to a 
secretory state by progesterone. When the progesterone 
is withdrawn, the sloughing or normal menses occurs. 
On the other hand, when progesterone has not acted 
upon the endometrium (as would be the case if ovula-
tion~had not occurred) and the endometrium has been 
stimulated only by estrogen, the woman will not ex-
perience menstrual type bleeding. She may experience 
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uterine bleeding, but this is usually of an irregular 
nature and due to fluctuations in the estrogen level. 
When the estrogen level decreases somewhat, the more 
superficial portions of the endometrium do not have 
adequate hormonal support and break away, often 
resulting in heavy and prolonged bleeding. These epi-
sodes of bleeding do not occur at any cyclic interval, 
and in fact the woman may experience no menses at 
all for prolonged lengths of time. 
The first vaginal bleeding cycles are commonly 
anovulatory. Some authors divide adolescence into 
early and late periods using the first ovulation as 
the dividing point. They consider early adolescence 
synonymous with puberty, beginning with the men-
arche and ending with the first ovulation, and define 
late adolescence as beginning with the first ovulation 
and ending when the woman becomes mature. Early 
adolescence may last two or more years, but may 
never occur if the girl ovulates before her first episode 
of vaginal bleeding. The young woman may then pass 
rapidly into the state where she is capable of normal 
reproduction, although the fact that a human female 
is able to produce a fertilizable egg is certainly not to 
say that she is mature. 
Amenorrhea 
If menarche has not occurred by age 16, some in-
vestigation is in order. A diagnosis of primary amenor-
rhea is not usually made until after age 18, but if no 
menses have occurred between age 16 and 18, the 
condition is called "delayed menarche." 
In cases of amenorrhea, a complete history should be 
taken, with particular emphasis on symptoms which 
could be caused by endocrine pathology or previous 
abdominal surgery. The family history should include 
menstrual and reproductive histories of the mother 
aunts and sisters. Examination of the patient should 
include a general physical examination as well as a 
pelvic exa~ination. Particular attention should be paid 
to lateral visual fields and the thyroid gland. The pres-
ence or absence of facial, axillary, pubic, chest and 
other body hair should be noted. Breast development 
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and general body habitus may also be significant. Some 
form of pelvic examination should be done for all 
of these girls. Certainly the external genitalia may 
be inspected and the clitoris examined. In the vast 
majority of these girls, a speculum examination of the 
vagina may be done, perhaps using a small speculum. 
The cervix may be visualized and a smear taken from 
the upper vaginal mucosa for a maturation index of 
the superficial cells. A gentle bimanual examination 
using one or two fingers is then done, and the uterus 
and adnexal areas palpated in this manner. A rectal 
examination is done routinely, and in some patients, a 
rectal examination will offer the only opportunity for 
palpation. In such patients with a small vaginal in-
troitus , inspection of the vagina may be performed 
using an endosope such as a culdoscope lens system. 
Several conditions may become apparent at the time 
of physical examination. The first of these is an im-
perforate hymen. The hymen is located at the site 
where the lower portion of the vagina buds from the 
urogenital sinus. If a lumen does not develop at the 
point where the vagina arises, the result is an imper-
forate hymen. Usually these are not discovered until 
puberty and symptoms may arise from the accumula-
tion of menstrual blood. Cyclic abdominal pain is a 
common symptom, but in some cases large amounts 
of blood can accumulate in the vagina, uterus and 
tubes without causing great discomfort. On examina-
tion, the hymenal membrane may be seen bulging and 
a mass will be palpated anteriorly on rectal examina-
tion. The treatment of this is simple incision or exci-
sion of a triangular flap. 
A transverse vaginal septum is a similar condition. 
It probably arises as a failure of union between the 
downgrowing Mullerian duct and the upgrowing uro-
genital sinus during embryologic life. In some cases, a 
transverse vaginal septum may be associated with a 
sinus tract through which the patient menstruates. In 
other cases, the septum may be complete and symp-
toms similar to those of imperforate hymen will be 
seen. Usually the septum will occur at the junction of 
the upper and middle thirds of the vagina, providing 
the girl with a short vagina. Unless the sinus tract is 
large enough to dilate, the treatment of this is surgi-
cal, the exact procedure being determined by the thick-
ness of the septum. This condition may be confused 
with testicular feminization, because in either case 
patients appear to be feminine and have short vaginas 
with no identifiable cervices. A buccal smear usually 
distinguishes the two groups, the patient with the im-
perforate hymen having a normal female Barr body 
present. 
Congenital absence of the vagina may also be pres-
ent. Sometimes these people have a normally devel-
oped lower vagina for a few centimeters, but most 
times the entire vagina and uterus are absent. The 
diagnosis is not usually made in infancy or childhood, 
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but instead the patient seeks medical advice because 
she has amenorrhea despite the development of normal 
secondary sex characteristics and growth. These girls 
have ovaries and usually have the upper portion of the 
fallopian tubes. These commonly end at about the level 
of the uterine cornua, although in some instances a 
rudimentary uterus without an endometrial cavity may 
be present. Urinary tract anomalies are associated in a 
significant number of these patients, so x-ray of the 
urinary tract is desirable. An artificial vagina can be 
satisfactorily created surgically. Following surgery, 
this has a tendency to constrict unless it is kept 
dilated, so surgery is deferred until about 6 months 
prior to marriage. This allows the operative site time 
to heal and during this time the patient wears a foam 
rubber dilator, initially all the time, and later only at 
night. After marriage, regular coitus is adequate to 
maintain dilatation. Some adolescent girls with con-
genital absence of the vagina will develop psychiatric 
problems because of this, and in this group the pro-
cedure may be done prior to any plans for marriage, 
"to keep her from being different." 
In cases of amenorrhea where there is no obvious 
physical cause, the initial laboratory work should in-
clude a test of thyroid function and a test to exclude 
the adrenal as a cause for the amenorrhea. These are 
currently done by obtaining serum for free thyroxine 
and a 24-hour urine collection for 17-ketosteroids. If 
there is any suggestion of Cushing's syndrome from 
physical examination or history, a 24-hour urine for 17-
hydroxysteroids should be collected. If there is any 
suggestion of adrenogenital syndrome, a determination 
of urinary pregnanetriol would be indicated. As noted 
earlier, a maturation index is obtained from the vagi-
nal mucosa. 
Once this initial laboratory work has been done, 
the patient is given a pure progestin to help establish 
the diagnosis of anovulation. If the patient's problem 
is simple anovulation, that is, she is producing ade-
quate estrogen but is not ovulating, the addition of a 
progestin such as oral medroxyprogesterone 10 mg 
daily for 5 days will result in withdrawal bleeding re-
sembling menses several days after the cessation of 
treatment. The progestin converts the proliferative 
endometrium to secretory endometrium and its with-
drawal is then followed by a slough of the superficial 
endometrium. If bleeding does occur, this ( 1) sug-
gests there is adequate endogenous estrogen being pro-
duced and that anovulation is the problem, (2) estab-
lishes the fact that the patient is not pregnant, and 
( 3) also establishes the fact that the patient has an 
endometrium capable of bleeding and that this blood 
has a passageway to escape from the uterus to outside 
the body. If the progestin is given and there is no 
withdrawal bleeding in 1 week, the patient is then 
given an estrogen as well as a progestin. This could be 
done by giving her oral norethynodrel 5 mg with 
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mestranol 0.075 mg daily for 5 days, or giving ethinyl 
estradiol 0.1 mg daily for 14 days with medroxy-
progesterone 10 mg daily taken concurrently on days 
10 through 14. If this is followed by withdrawal bleed-
ing, this indicates that ( 1) the patient is not produc-
ing endogenous estrogen, (2) she is not pregnant, and 
( 3) the endometrium is capable of bleeding and the 
flow can escape. This is a group of patients in which 
the assay of pituitary gonadotropins is useful in estab-
lishing the cause of no estrogen production. Total 
pituitary gonadotropin in the urine should be either 
high or low, but not normal. If the value is high, it 
would indicate that this primarily is an ovarian prob-
lem, and despite high levels of gonadotropins the ovary 
is not producing estrogen. If, on the other hand, 
pituitary gonadotropins are low, it would indicate that 
the ovary is not being stimulated. 
The patients who do not bleed after estrogen and 
progestin therapy should be carefully evaluated for a 
possible pregnancy. Once this possibility has been ex-
cluded, the cervix should be sounded to rule out the 
possibility of cervical stenosis and the uterine cavity 
probed to establish the fact that there is, indeed, a 
cavity to the uterus. In most instances, this can be 
done in the office without hospitalization. 
Most of the patients seen for amenorrhea will be 
found to have anovulation and to be producing ade-
quate endogenous estrogen. They may then be treated 
with oral medroxyprogesterone 10 mg daily for 5 days, 
beginning cycle day 22 of each month. This will result 
in regular withdrawal bleeding, occurring about every 
28 days and lasting a normal length of time. When 
administered in this way, the drug certainly will not 
interfere with spontaneous ovulation, should it occur. 
Until spontaneous ovulation does occur, the patient 
will experience regular bleeding. Such medication may 
be administered for 6 months and then temporarily 
discontinued to see what bleeding pattern the patient 
will exhibit on her own. After experiencing several 
such episodes of bleeding, some girls indicate that they 
would rather not be bothered with vaginal bleeding at 
monthly intervals. It is beneficial for the superficial 
endometrium to experience a slough as normally oc-
curs from a secretory endometrium several times a 
year, so this group of girls may be given a progestin 
at 4 month intervals until spontaneous menses begin. 
The amenorrhea associated with anovulation may be 
secondary to psychogenic factors. Psychic shock, fear, 
unhappy home or school conditions, and insecurity can 
cause both primary and secondary amenorrhea. Some-
times this is associated with simple anovulation but at 
other times the patient stops producing estrogen also. 
In this latter group, the administration of progestin 
alone will not result in withdrawal bleeding and the 
patient must receive estrogen priming before such 
withdrawal bleeding will occur. If pituitary gonado-
tropin levels are low in the face of no endogenous 
estrogen production, p1tmtary and hypothalamic pa-
thology should be excluded. Old injuries (such as 
from high fever or trauma), tumor and pharmacologic 
effects should be ruled out. The history, skull x-rays 
and visual fields are particularly helpful here. In a few 
cases of hypothalamic disease, amenorrhea will be asso-
ciated with galactorrhea, but such cases are rare. 
Other causes of amenorrhea with a hormonal basis 
include Turner's syndrome, gonadal dysgenesis without 
Turner's syndrome, testicular feminization, adreno-
genital syndrome and polycystic ovary syndrome 
(Stein-Leventhal syndrome). 
In Turner's syndrome, the condition begins with an 
accident in miosis or mitosis of the ovum. These 
people have only one sex chromosome instead of two, 
and when the area normally occupied by ovaries is 
examined, usually only a streak of fibrous tissue is 
found. Histologically this resembles ovarian stroma 
which contains no follicles. These individuals do not 
ovulate or produce estrogen or progesterone and their 
pituitary gonadotropin levels are high. In addition to 
the lack of any secondary sex characteristics and 
menstruation, there are associated findings which are 
not caused by estrogen lack. These include shortness 
of stature, scant pubic and axillary hair, exaggeration 
of the carrying angle of the elbow, webbing of the 
neck, and coarctation of the aorta. These patients do 
have a vagina and uterus, and when exogenous estro-
gen and progestin are administered, they will develop 
secondary sex characteristics and have menses. 
Some women will also have streak ovaries which 
do not produce estrogen but present an entirely differ-
ent clinical picture. These women have normal female 
sex chromosomes, and all of their findings are second-
ary to the absence of gonads. The associated findings 
of Turner's syndrome are absent. Instead of being 
short, these patients are eunuchoid, tall, and have an 
appearance similar to that seen in persons castrated 
prior to puberty. These patients may be also treated 
with estrogen and progestin. In these cases, epiphyseal 
closure may be promoted and there will also be de-
velopment of secondary sex characteristics and menses. 
Individuals with testicular feminization have the XY 
chromosome compliment seen in normal males, but 
certainly do not appear to be males. In fact, these 
patients on cursory examination appear to be normal 
females. They are of normal height, have normal 
breast development, and are not hirsute. Pelvic exami-
nation will disclose a short vagina and the absence of 
a uterus. There is usually scant or absent axillary and 
pubic hair and the patient may have an inguinal 
hernia or evidence of a previous herniorrhaphy. The 
hernias are associated with cryptorchid testes. The 
clinical findings are due to a lack of end-organ re-
sponse to androgens. All testes normally secrete some 
estrogen as well as testosterone. In these people with 
testicular feminization the testosterone exerts no pe-
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ripheral effect, so estrogen is the only sex hormone 
acting, and female secondary sex characteristics de-
velop. Since these cryptorchid testes have a malignant 
potential, removal has been advocated, and after cas-
tration, testosterone levels fall precipitously and estro-
gen levels fall somewhat less dramatically. Following 
this surgery, most of these patients should be given 
replacement estrogen medication. 
The adrenogenital syndrome due to congenital ad-
renal hyperplasia has its onset in intrauterine life. It is 
due to enzyme blockage in the adrenals with resulting 
elevation of urinary 17-ketosteroids. There are several 
types of this syndrome, but the most common one has 
a partial block in the synthetic pathway for cortisol 
resulting in the production of 17-ketosteroids and 
pregnanetriol. In addition to the amenorrhea, these 
people will have early development of hirsutism, ac-
celerated development in length and weight, advanced 
bone age on x-ray and associated virilization. Treat-
ment with cortisol will result in the onset of ovulatory 
menses and in many cases reduction of the hirsutism. 
When hirsutism is associated with amenorrhea, one 
should also exclude adrenal and ovarian tumors as 
well as Cushing's syndrome. 
Patients with polycystic ovary syndrome will have 
bilaterally enlarged polycystic ovaries and failure of 
ovulation. Typically, a girl goes through normal early 
adolescence and may even ovulate for a time before 
stopping. In some cases there may be no spontaneous 
menses. Hirsutism may be mild or severe; but viriliza-
tion does not occur. The ovaries in this condition are 
about two to four times normal size and contain many 
small follicles beneath the capsule. The primary defect, 
however, is not thought to be in the ovary, but in the 
hypothalamus or higher centers resulting in an im-
proper secretion of pituitary gonadotropins. The tra-
ditional treatment for polycystic ovary syndrome was 
wedge resection of the ovaries. In some manner, re-
duction of ovarian mass changed the feedback effect 
on the hypothalamus, and pituitary gonadotropins 
were then secreted in a proper ratio. Such effects did 
not last forever, and commonly after a year or so of 
ovulatory menses, the original condition returned. 
More recently, it has been possible to induce ovulation 
in most of these women by the use of clomiphene 
citrate or menopausal gonadotropin. This is given only 
during the months when pregnancy is desired. In order 
to have regular menses at other times, withdrawal 
bleeding from exogenous sex steroids may be utilized. 
In most cases, sequential estrogen-progestin is given 
here, because the estrogen has a beneficial effect on 
the hirsutism; the progestin then induces a secretory 
change in the endometrium resulting in a menstrual 
type slough when the progestin is withdrawn. In some 
cases, the estrogen is given continuously; in others, 
both estrogen and progestin may be stopped on the 
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same date, with the estrogen therapy being resumed 
one week later. 
Menorrhagia and Metrorrhagia 
Anovulation may also manifest itself by episodes 
of frequent, heavy or prolonged vaginal bleeding. The 
work up and long-term therapy of such patients is the 
same as when the primary symptom was amenorrhea. 
There is in addition, however, the initial problem of 
getting the bleeding stopped. Dilatation and curettage 
of the uterus is only rarely needed. Most of these girls 
will stop bleeding when treated with estrogen. Their 
bleeding has occurred when their circulating estrogen 
level has dropped, so they may be logically treated by 
exogenous estrogen. In some cases, oral estrogen is 
adequate therapy. In other cases, when hemorrhage 
has been profuse, bleeding may be controlled by the 
administration of intravenous conjugated estrogens 20 
mg, repeated once in 6 hours if necessary. At the same 
time that intravenous therapy is given, oral medication 
is also started. The patient may be given oral con-
jugated estrogens 1.25 mg three times a day, ethinyl 
estradiol 0.1 mg daily, or any of the commercially avail-
able oral contraceptive tablets (preferably those with 
higher estrogen content). When oral estrogen alone is 
given, the patient should take this medication for 21 
days and on the last 5 days should take medroxy-
progesterone 10 mg. This will cause secretory changes 
in the estrogen stimulated proliferative endometrium 
and will result . in normal type bleeding when both 
estrogen and progestin are withdrawn. In subsequent 
months, medroxyprogesterone alone administered 10 
mg a day for 5 days, beginning cycle day 22, is usu-
ally adequate to prevent abnormal bleeding. 
Dysmenorrhea 
Painful menstruation during adolescence is usually 
primary; that is, it is not associated with congenital 
anomalies or organic disorders. Such discomfort usu-
ally does not appear until several years after the 
menarche, and is thought to appear at the same time 
that the girl begins to ovulate and have ovulatory 
menses rather than while she is having anovulatory 
bleeding episodes. A distinction was previously made 
between early and late adolescence on a basis of 
whether menses were ovulatory. If that classification 
is retained, primary dysmenorrhea is a symptom of 
late adolescence. 
Dysmenorrhea pain is recurrent, sharp, and cramp-
ing or contraction like in character. It is usually 
located in the suprapubic area and may precede the 
onset of flow, may not occur until bleeding actually 
occurs, or may not appear until after bleeding has 
been established for several days. Associated symp-
toms may include malaise, headache, backache and 
lethargy. Since this is usually associated with ovula-
tory menses, these girls usually do not have any his-
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tory of menstrual irregularity, but instead have quite 
regular menses. 
The cause of primary dysmenorrhea is not known. 
It most likely has something to do with uterine con-
tractions, but the exact nature of this is not clear. In 
addition, there seems to be some psychogenic influence 
in that some girls have been conditioned in childhood 
by their mothers or older sisters to look upon men-
struation as "being sick." Physical examination, of 
course, should be done, in an effort to rule out any 
organic or congenital obstruction to menstrual flow. 
The milder cases can be treated with a combination 
of mild analgesics and amphetamine. Such medication 
should not be taken at night, but the effects of am-
phetamines as a uterine muscle relaxant are beneficial 
and useful during daytime. If the patient continues to 
has severe symptoms, the use of an estrogen-progestin 
combination oral contraceptive agent is useful. This 
inhibits ovulation, but supplies exogenous progestin. 
How this prevents dysmenorrhea is unclear, but it does 
so in a majority of these patients. Some physicians 
worry about the propriety of giving a medicatiOn 
which can be recognized as a contraceptive agent to an 
adolescent girl, fearing that if she knows the effects of 
the medication this will inspire her to engage in pre-
marital coitus. As other contraceptive methods are 
readily available over-the-counter at drugstores and 
even at discount stores, the availability to her of an-
other contraceptive method is not likely to influence 
the girl's social behavior. Since combination oral con-
traceptive agents have been used for this purpose, the 
number of presacral neurectomies done to relieve 
dysmenorrhea has diminished greatly. 
Mittleschmerz or ovulatory pain also is a symptom 
of late adolescence as opposed to early adolescence. 
The discomfort is usually described as a slight ach-
ing in one side of the lower abdomen, although it may 
be quite severe. At times, it is so severe that when it 
is located on the right side, the possibility of appendi-
citis is seriously entertained. The cause of midcycle 
pain is unknown. Moderate amounts of free blood do 
not cause peritoneal pain, but in some manner the 
peritoneum becomes irritated. The menstrual history 
and the time of occurrence of the pain are most useful 
in making the diagnosis. 
Leukorrhea 
Not all vaginal discharge is pathologic. Increased 
vaginal fluid is very common in adolescent girls. The 
girl may interpret the normal estrogen stimulated 
secretion of the endocervical glands as a pathologic 
condition. In a normal ovulatory cycle, such secretion 
is greatest at the time of highest unopposed estrogen 
levels, that is immediately before ovulation. In early 
adolescence, estrogen is the only hormone which is 
acting upon the endocervical glands, and such secre-
tion may be present continuously. When the girl begins 
to ovulate, such secretion will diminish and will be of 
increased volume for only several days each month. 
The second most common cause of leukorrhea in 
adolescent girls is infection with Candida albicans. 
The increased incidence in diabetic females is well 
known. Systemic antibiotic therapy may be followed 
by Candida infection, and pregnancy as well as ther-
apy with oral estrogen-progestin contraceptive tablets 
may also predispose to this. The scanty discharge is 
thick, white and curd-like in appearance. In addition 
to leukorrhea, the patient may have vaginal and vulvar 
puritis with associated excoriation on the vulvar 
areas. The diagnosis can usually be made by inspection 
of the vagina and may be confirmed by culture on Nick-
erson's media. Culture tubes containing Nickerson's 
media are available commercially and may be incu-
bated at room temperature for 2 days and subse-
quently examined in the physician's office. 
Infections may be treated first with nystatin vaginal 
suppositories which are inserted twice daily for 12 
days. If vulvitis is also a symptom, nystatin cream is 
applied here. If the nystatin does not clear up the 
infection, gentian violet may be used. This is highly 
effective in eliminating the condition but the purple 
staining of undergarments, bed sheets and towels may 
be a problem. 
Vaginal trichomoniasis is relatively uncommon in 
the younger adolescent. It becomes more common as 
the girls grow older and is particularly common in 
girls who have had intercourse. On the other hand, the 
number of cases in which vaginal trichomoniasis oc-
curs without the possibility of direct sexual contact 
with an infected male is so large that we must con-
sider this a disease that can be transmitted several 
ways, only one of which is by coitus. The girl will 
complain of an irritating profuse discharge. There may 
be perinea! itching or burning with micturition and 
sometimes the symptoms are worse just before and 
immediately after menses. On examination the vagina 
is filled with a copious frothy, watery, dirty ivory col-
ored fluid. When the vaginal mucosa is involved 
severely, a strawberry or red punctate vaginal erup~ 
tion may be seen, but many cases of vaginal tri-
chomonous exist without this finding. The diagnosis is 
made by finding Trichomonas vaginalis in wet smears 
of the vaginal fluid. The fluid should be examined 
immediately after being diluted with warm isotonic 
saline solution. Hypotonic solutions as well as cooling, 
drying or changes in the pH will quickly kill the 
organisms. The organisms, which are protozoa, may 
be seen swimming about on the wet smear. Vaginal 
trichomoniasis may be treated with metronidazole 250 
mg three times a day for 10 days. 
Non-specific vaginal inflammations are commonly 
associated with leukorrhea in adolescent girls. There 
is little or no irritation or discomfort due to this 
leukorrhea except that there may be some dysuria. 
95 
GYNECOLOGICAL PROBLEMS 
There is usually no vulvar inflammation, but the 
vagina is inflammed and the discharge varies from a 
scanty thin fluid to a purulent grayish-yellow leukor-
rhea which is profuse enough to necessitate the wear-
ing of perineal pads. These cases, as well as mixed 
infections with monilia or trichomonas, may be 
treated with vaginal suppositories of furazolidone with 
nifuroxinie. Sometimes the non-specific vaginitis is 
associated with a congenital cervical erosion or an 
erosion which is secondary to the vaginitis. Such ero-
sions do not usually need cautery and if they are 
secondary to the vaginitis, they clear up when the 
vaginitis clears. 
Venereal Disease 
Acute gonorrhea is accompanied by a profuse puru-
lent, yellowish green discharge. This will appear 3-8 
days after the girl has had coitus with an infected 
male and may be associated with dysuria or vulvar 
burning. In some cases there is very little discomfort. 
The profuse, thick, creamy vaginal discharge may per-
sist after the acute symptoms have gone away and 
may be seen to be coming primarily from an eroded 
cervix. There may be associated infection of the 
Bartholin's glands or of the periurethral glands. Un-
fortunately, female patients are not as aware as males 
of a urethral discharge and 80% of females with 
gonorrhea are asymptomatic. The gonococcus usually 
does not rise above the internal uterine os except 
during menses and this results in symptoms of acute 
salpingo-oophoritis commonly occuring just after 
menses. The patient will have bilateral lower abdomi-
nal pain and tenderness, adnexal thickening and ten-
derness, fever and leukocytosis. Pelvic peritonitis, with 
rebound tenderness and a palpable abscess in the tube 
or ovary may be associated findings. Gram stain may 
be applied to smears, and cultures may be made on 
the new Theyer-Martin or Lesser-Martin culture 
media which is most specific for gonococcus. The re-
sults are available in 48 hours, and as a screening 
technique this method will pick up about 90 % of the 
cases. It is probably best to take smears from the 
cervix, vagina, urethra and rectum. The treatment of 
acute gonorrhea in the female is a single injection of 
4.8 million units of procaine penicillin G . 
Patients with gonorrhea should also be examined 
for syphilis, using the absorbed flourescent Treponema 
antibody test. This becomes positive in about 20 days 
after exposure, so it is positive during the time of the 
primary lesion. The presence of a chancre on the 
vulva, in the vagina or on the cervix, is rarely noted 
and the manifestations of secondary syphilis may be 
the first symptoms noted by the patient. The primary 
lesion, or chancre, develops at the site of innoculation, 
3 to 6 weeks after the Treponema pallidum enters the 
body. It rarely is a well-defined punched out ulcer 
with a hard base, as seen in the male, but may be a 
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painless, flat, moist abrasion or a flat, superficial, 
excoriated type of ulcer. The chancre heals sponta-
neously, and about 6 weeks after its appearance, 
secondary syphilis may appear. This is typically mani-
fested as a symmetrical, macular, papular, non-irritat-
ing rash which may involve the palms and soles as 
well as the trunk and extremities. Other findings in-
clude mucous patches of the oral mucosa, condylomata 
lata, iritis or neurorectinitis, alopecia, generalized 
lymphadenopathy, and constitutional symptoms such 
as malaise, lassitude, headaches and fever. The VDRL 
( cardiolipin) test is positive by the time secondary 
syphilis is noted. The treatment of primary or sec-
ondary syphilis is a single injection of 2.4 million units 
of benzathine penicillin G. 
Rape 
From time to time, girls allege that rape has oc-
curred and they seek medical attention. If the victim 
is not brought in by the police, officials should be 
notified. The definition of rape varies from state to 
state. In Maryland, for instance, penetration of the 
vagina by the penis is required, but in the Common-
wealth of Virginia rape occurs when force is used to 
cause contact of genitalia without consent of the per-
son being raped. Statutory rape, on the other hand, 
occurs when the girl gives consent to coitus but is 15 
years of age or under. 
An evaluation for suspected rape should include a 
good history, which should be obtained and written 
down as quotations in the patient's words. The time, 
place and circumstances should be recorded, as well 
as the patient's emotional state and whether a bath had 
been taken since the incident occurred. The examina-
tion should include a statement concerning the gen-
eral appearance of the patient including evidence of 
trauma such as bruises, lacerations or torn clothes. 
Particular attention should be paid to evidence of 
trauma about the external genitalia. A speculum ex-
amination should then be carried out with a non-
lubricated speculum. A cotton swab should be satu-
rated with fluid present in the vaginal cavity. A small 
portion of this should be put on each of two glass 
slides and allowed to dry. The swab should then be 
placed in a test tube and sealed with a cork. These 
specimens will be examined microscopically for sperm 
and biochemically for acid phosphatase. These speci-
mens, along with any garments that appeared to con-
tain stain, should be labeled with the name of the 
victim, date and hour of alleged rape, hour of medi-
cal examination and name of physician. All of this 
"evidence" should be securely kept under lock until 
arrangements have been made for transfer to a desig-
nated local laboratory or to the office of the Chief 
Medical Examiner. If it is to be mailed, certified mail 
or insured mail with return receipt should be used. 
The oral administration of 25-50 mg of stilbestrol a 
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day for 5 days or the oral administration of 2-5 mg a 
day of ethinyl estradiol for 5 days, beginning ther-
apy the day after coitus, consistently prevents im-
plantation. The primary side effect with this therapy 
is nausea and vomiting. Sometimes this is quite severe, 
in spite of the concomitant administration of an-
tiemetic agents. The nausea and vomiting, however, is 
usually experienced on the first day of therapy and the 
remaining 4 days are associated with this symp-
tom. The patient may experience breast soreness and 
the first menses after therapy may be associated with 
menorrhagia. The mechanism of action is still unclear. 
The expected basal body temperature rise is frequently 
inhibited, and the endometrial histologic picture does 
not progress normally. Perhaps the endometrium is 
made more acid, and this contributes to failure of 
implantation. 
Since the attacker may have had a venereal disease, 
some physicians give prophylactic antibiotic therapy. 
If there is no indication of penicillian allergy, 2.4 mil-
lion units of benzathine penicillin may be used. 
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